Raisonance
- Company typePrivate
- Founded2020
- HeadquartersGreenwood Village, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Raisonance firmographics
Firmographics- Name
- Raisonance
- Legal name
- RAIsonance, Inc.
- Website
- https://raisonance.ai
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Raisonance industry classification
Industry- Product category
- AI Clinical Decision Support Software
- NAICS
- Medical Laboratories (621511), Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)
- akta.pro secondary industries
- SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE), Medical Imaging AI (HDAAAEAH)
Keywords
Where Raisonance is headquartered
LocationHeadquarters
- HQ city
- Greenwood Village
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Raisonance business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Supply Chain
Revenue model
- Enterprise / Institutional Software Licensing (AudibleHealth AI): Clinical decision support screening software licensed to healthcare providers, government health programs, military, and pharmacy chains for respiratory disease screening (TB, COVID-19, Pneumonia, Influenza). Pricing model not publicly disclosed; contracts and pricing are quote-based.
- Subscription / SaaS (FCV Sentinel): FCV Sentinel biometric early-warning service for individuals, large employers, colleges/universities, airline and cruise passengers. Includes interactive aggregate dashboards for organizational customers; recurring SaaS revenue model inferred from continuous monitoring use case.
- Government / Defense Contracts (BARDA): AudibleHealth AI respiratory screening software was developed in part under contract from BARDA (Biomedical Advanced Research and Development Authority) to detect COVID-19 and Influenza. Revenue generated via federal contracting channel.
- Exempt Securities Offering / Equity Financing: Form D exempt securities offering of $6.5 million total, with $2.5 million sold at time of filing (SEC, 2022-08-11). Capital-raising activity supporting company growth.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Quote-based enterprise contract for AudibleHealth AI screening |
| Subscription | — | Quote-based subscription for FCV Sentinel with enterprise dashboards |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels9 records
Raisonance product offering
Product offeringCore offering
Raisonance develops AI/ML-based cough analysis software that screens for respiratory diseases (Tuberculosis, COVID-19, Pneumonia, Influenza) and provides biometric early-warning monitoring via a smartphone-based platform. Its core product AudibleHealth AI is a clinical decision support tool that analyzes a 10-second cough recording against 5,000+ data points, delivering results in approximately 30 seconds on Microsoft Azure cloud infrastructure, with FDA Emergency Use Authorization and ISO 13485 certification.
Product overview
Raisonance operates a single underlying AI technology platform — Forced Cough Vocalization (FCV) Signature Analysis — which powers two core commercial product lines: AudibleHealth AI, a clinical decision support product that screens for specific respiratory diseases (currently Tuberculosis and COVID-19, with Pneumonia and Influenza in final testing) using a 10-second smartphone cough recording analyzed in Microsoft's Azure cloud in ~30 seconds; and FCV Sentinel, a biometric early-warning monitoring product that tracks an individual's FCV scores against their unique baseline and surfaces notable changes as an FCV Impact Score. Together with an industry-specific FCV Smoker Detection module for insurance underwriting, the two commercial lines share the same patented AI/ML pipeline that analyzes over 5,000 data points per cough, live across multiple countries and supported by a BARDA contract for COVID-19 and Influenza development.
Differentiator
Problem solved
Functional benefit
Brands
- AudibleHealth AI: Clinical decision support software designed to detect disease signatures in a cough sound; screens for respiratory diseases such as Tuberculosis, COVID-19, Pneumonia, and Influenza via a smartphone-based cough recording.
- FCV Sentinel
- FCV Wellness
Products and services
- AudibleHealth AI Clinical decision support software that screens for respiratory diseases by analyzing a cough sound collected via a smartphone app. Users cough for ~10 seconds and receive results in ~30 seconds, with no swabs, waste, or waiting. Currently screens for Tuberculosis and COVID-19, with Pneumonia and Influenza in final testing and 15+ additional test types on the roadmap. Developed in part under a BARDA contract for COVID-19 and Influenza.
- FCV Sentinel Threat-agnostic early warning system based on Raisonance's proprietary Forced Cough Vocalization (FCV) analysis. Tracks FCV scores over time to flag notable changes in an individual's respiratory profile; delivers an FCV Impact Score (0-99) and aggregate dashboards for organizations. Does not diagnose conditions or distinguish between pathogens and chemical agents.
- FCV Smoker Detection Solution built on the AudibleHealth AI platform for the insurance underwriting industry that identifies whether an individual is a cigarette smoker based on cough analysis.
Quantifiable outcome
- ~30 second result turnaround from 10-second cough recording
- +5 more outcomes
Companies that use Raisonance
Customer profileSegments7 records
Ideal customer profiles5 records
Raisonance technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
Raisonance partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered flagship, core and minor.
- Microsoft AzureflagshipCloud production infrastructure partner. RAIsonance solutions run on Microsoft Azure; cough recordings are pushed to the Azure cloud and results returned in approximately 30 seconds. The scalable Azure infrastructure can currently process over 20,000 screenings per second. Also an alumnus/affiliate of Microsoft for Startups (logo displayed on website).
- BARDA (Biomedical Advanced Research and Development Authority)flagshipU.S. federal contracting partner. AudibleHealth AI respiratory screening software was developed in part with a BARDA contract to detect COVID-19 and Influenza.
- THE 5Ps, LLC (Major General Elder Granger)flagshipStrategic Advisory Lead for Government and Military Medical Programs. General Granger (retired U.S. Army Major General) appointed April 2026 to lead RAIsonance's global strategic efforts with government and military programs, drawing on prior leadership of TRICARE (overseeing 9M+ beneficiaries) and the 44th Medical Command.
- Christine Hrudka (Pharmacy Industry Strategic Advisory)flagshipStrategic Advisory Lead for the Pharmacy Industry appointed January 2026. Former Chair of Canadian Pharmacists Association; 20+ years operating Shoppers Drug Mart locations; will lead pharmacy programs across Canada, the United Kingdom, Australia and the US.
- DRIVe (Division of Research, Innovation, and Ventures)coreListed as partner on Our Partners page linking to drive.hhs.gov/digitalmcm.html, indicating engagement with HHS DRIVe (often a BARDA-adjacent innovation accelerator).
- SotorcoreFeatured partner on RAIsonance's Our Partners page linking to sotertechnologies.com. Likely regional distribution or technology collaboration partner.
- Biotech LatamcoreFeatured partner on Our Partners page linking to biometric.biotechlatam.solutions, suggesting Latin American distribution or biometric services collaboration.
- Health Express 365coreFeatured partner on Our Partners page linking to healthexpress365.com, likely a healthcare distribution or screening services partner.
- Well BeforecoreFeatured partner on Our Partners page linking to wellbefore.com, likely a consumer/retail health products distribution partner.
- AbundaboxminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- AequusminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- BibeatminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- DawapayminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- HippominorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- KompsysminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- MaatminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- NIHTBminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- SalessquadminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- ZachminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
- ZendawaminorListed on Our Partners page; logo only without linked URL, indicating a smaller emerging-market distribution relationship.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Raisonance competitors and assessment
Company assessmentDirect peers
- ResApp Health: Australian digital health company (acquired by Pfizer in 2022) that developed machine-learning analysis of cough sounds to diagnose respiratory diseases including pneumonia, asthma, and COPD. Closest direct peer to RAIsonance's AudibleHealth AI cough-based clinical decision support product.
- Hyfe AI: AI cough-monitoring platform that analyzes cough frequency and patterns via smartphone microphones for respiratory disease tracking. Closely comparable to RAIsonance's FCV Sentinel use case of continuous cough-based monitoring, with a more research/consumer-research orientation.
- Sonde Health: Voice biomarker platform using vocal audio analysis (including cough) for health monitoring and mental/physical condition detection. Directly comparable to RAIsonance's audio-based biomarker approach, though Sonde has emphasized mental health and cognitive conditions rather than respiratory screening.
- Eko Health: Digital stethoscope plus AI platform that analyzes lung and heart sounds for respiratory and cardiac conditions, including FDA-cleared AI for detecting pulmonary conditions. Comparable AI-audio respiratory diagnostics competitor, though Eko uses a dedicated stethoscope rather than a generic smartphone.
- NuvoAir: Digital respiratory health platform combining remote spirometry, symptom tracking, and AI for asthma/COPD management. Comparable to RAIsonance's respiratory disease screening and monitoring product set, with overlapping enterprise payer/provider business models.
Emerging players
- Kintsugi: Voice biomarker startup using short voice clips to detect depression and other mental/physical health conditions. Comparable as an emerging audio-biomarker health AI company with a different clinical focus (mental health) than RAIsonance's respiratory focus.
Others
- Cepheid (Danaher): Maker of GeneXpert molecular diagnostic systems (the confirmatory TB/COVID testing RAIsonance flags patients for). Indirectly tied to RAIsonance as the downstream confirmatory testing modality; not a competitor but the established incumbent whose installed base RAIsonance's screening complements rather than displaces.
- Health Catalyst: Healthcare data and analytics platform serving hospitals and health systems. Indirect adjacency: Health Catalyst sits in the hospital IT/analytics stack where RAIsonance's screening outputs would integrate, rather than directly competing in respiratory diagnostics.
Broad incumbents
- Babylon Health: AI-powered digital health and triage company offering symptom assessment and virtual care across multiple disease areas. Broad incumbent in AI health screening; competes for the same enterprise/payer budgets that fund AI-driven respiratory screening pilots.
- Biofourmis: AI-based remote patient monitoring and digital therapeutics platform focused on chronic conditions including respiratory. Comparable as a broader AI health monitoring incumbent, especially relevant to RAIsonance's FCV Sentinel enterprise monitoring use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Raisonance social profiles
Digital presenceRaisonance compliance and trust
Trust signalCompliance2 records
Raisonance financial estimates
Financial estimateRevenue estimate
Valuation estimate
Raisonance leadership team
Management profileNumber of profiles
Profiles19 records
Raisonance funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Raisonance M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Raisonance
What does Raisonance do?
Raisonance develops AI/ML-based cough analysis software that screens for respiratory diseases (Tuberculosis, COVID-19, Pneumonia, Influenza) and provides biometric early-warning monitoring via a smartphone-based platform. Its core product AudibleHealth AI is a clinical decision support tool that analyzes a 10-second cough recording against 5,000+ data points, delivering results in approximately 30 seconds on Microsoft Azure cloud infrastructure, with FDA Emergency Use Authorization and ISO 13485 certification.
Is Raisonance a public or private company?
Raisonance is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Raisonance founded?
Raisonance was founded in 2020. It employs 11 to 50 people.
Where is Raisonance based?
Raisonance is headquartered in Greenwood Village, United States, in the North America region.
How does Raisonance make money?
Four revenue lines are on record. Enterprise / Institutional Software Licensing (AudibleHealth AI) is the primary driver. The others are subscription / SaaS (FCV Sentinel), government / Defense Contracts (BARDA) and exempt Securities Offering / Equity Financing.
Who are Raisonance's main competitors?
Direct peers on record are ResApp Health, Hyfe AI, Sonde Health, Eko Health and NuvoAir. Kintsugi is listed as an emerging player. Others are Cepheid (Danaher) and Health Catalyst. Broad incumbents are Babylon Health and Biofourmis.
Does Raisonance have an API?
No public API is recorded for Raisonance.
What industry is Raisonance in?
Raisonance's product category is AI Clinical Decision Support Software. Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software, with a secondary code of HLACANAE, SaMD – Monitoring, Triage & Risk Stratification Software. Its NAICS code is 621511 and its SIC code is 7372.